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Abstract   
Introduction: The aim of this in vivo study was to determine the effect of demineralized 
bone matrix (DBM) on alveolar bone repair in type I diabetic rats. 
Materials and Methods: This study was carried out on 40 adult (8 weeks-old) albino rats 
with an average weight of 200-250 grams. The animals were divided into four groups (n=10) as 
follows: group 1 nondiabetic rats, group 2, 3 and 4 were diabetic rats, group 4 rats took one unit 
of insulin daily.  Diabetes was induced by Alloxan Monohydrate through the tail veins of the 
rats in groups 2-4. Only group 4 received insulin NPH 1 unit daily. After 10 days, the upper 
right incisors of all samples were extracted and the socket was filled with DBM in groups 3 and 
4. The animals were sacrificed at the end of week 1 and 2. The specimens were prepared and 
stained with H&E. 
Results: Histological results of group 4 displayed osteoblastic activity and bone formation 
with collagen fibers at the end of the first week and thick bone trabeculae formation in vicinity 
of DBM at the end of second week. In group 3, DBM showed some osteoinductivity at the end 
of the first week, but in some regions DBM particles were degraded by osteoclastic activity. 
Bone trabeculae formed with a dispersed and separate pattern at the end of second week. In 
group 2 hematoma and inflammation were dominant histological features at the end of first and 
second weeks; poor bone formation was detected in these two groups (2 and 3). In group 1, the 
results were as expected.  
Conclusion: It seems demineralized bone matrix simulate osteoblastic activity. [Iranian 
Endodontic Journal 2009;4(1):20-4] 
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Introduction 
The two major types of diabetes are type 1, 
formerly known as "insulin-dependent diabetes 
mellitus" (IDDM) and type 2 formerly called 
"non-insulin-dependent diabetes mellitus 
(NIDDM)". During the past decade, medical 
management of diabetes has changed 
significantly to minimize the debilitating 
complications associated with this disease. 
Type 1 diabetes is one of the metabolic 
diseases that involve increase in blood sugar 
and disturbance in carbohydrate, lipid and 
protein metabolism (1). Decrease in bone repair 
and formation are one of the consequences and 
signs of diabetes (2). Demineralized freeze 
dried bone allograft (DFDBA) or demineralized 
bone matrix (DBM) and autogenous grafts are 
some of the used materials in guided bone 
regeneration (GBR) (3-5). DBM is one of the 
allograft materials employed in periodontal 
surgery, bone regeneration, infection and 
trauma (6), first utilized by Urist (7).  




IEJ -Volume 4, Number 1, Winter 2009 
DBM & alveolar socket healing 
 
Figure 1. Tissue sections from the alveolar socket 
of the forth group [first week]. 1) DBM, 2) 
osteoblasts, 3) Forming bone, 4) Collagen 
 
This material had great success in repair of 
calvarial bone defects (8). There have been 
controversial reports regarding the induction 
and guided bone regeneration ability of DBM 
materials; however the increased popularity of 
synthetic materials has limited the use of DBM 
in maxillofacial surgeries (3). Induction and 
guided bone formation of DBM may be due to 
the presence of bone morphogenic protein 
(BMP). These proteins are considered 
important factors in the formation of limbs in 
addition to their key role in bone regeneration 
(9). Investigations to introduce and recognize 
DBM as a grafts material are still in process 
(10). Hence the aim of this in vivo study was to 
determine the effects of DBM on alveolar bone 
repair of diabetic rats (type I). 
 
Materials and Methods  
This in vivo study was performed according to 
other similar studies (8,11-13). All experiments 
were conducted according to the guideline of 
local animal use and care committees and 
executed according to national animal law.  
Forty 8-week old albino rats with an average 
weight of 200-250 grams were selected and 
randomly divided into 4 groups of 10 each (11). 
Group 1 was non diabetic and the other 3 
groups were diabetic. For creating diabetes in 
diabetic groups, we diluted a vial of 
monohydrate Alexon (St. Louis, MO, USA) 
with buffer saline, then injected 52 mg/kg of 
this solution to the rats immediately after its 
preparation through tail veins by insulin 
syringe (12). 
 
Figure 2. Section from the trabecular bone of the 
forth group [second week]. 1) Formed trabeculas, 
2) Osteoblasts, 3) Osteocytes 
 
Five days after injection, blood samples were 
derived through retro-orbital venous sinus by 
means of micropipette in samples of groups 2, 
3, and 4. Blood sugar level showed an increase 
from 7 mmol (normal) before injection to 13 
mmol after injection. During treatment, blood 
sugar was kept stable at approximately 7 mmol. 
Rats in group 4 (insulin treated, diabetic) took 1 
unit of NPH insulin daily (11).  
Ten days after diabetes induction, general 
anesthesia was performed by 10mg/kg Ketamin 
HCl (Alfanso, the Netherland) and 1mg/kg 
chlorpromazine injection, and then upper right 
incisor of each rat was extracted. After 
hemostasis was achieved in groups 3 and 4, the 
dental sockets were filled with mixed saline 
and DBM, the area was then sutured. In groups 
1 and 2 dental sockets were not filled. Finally, 
2 mL of pentabioticveternario (sigma type 
antibiotic) was injected intramuscularly (11).  
At the end of two weeks, five rats from each 
group was randomly separated and beheaded 
under general anesthesia and placed in 10% 
formalin. After that, decalcification was 
performed by means of formic and chloridric 
acids (Kiyankaveh, Iran) for one week and 5-
µm tissue sections were prepared and stained 
by hematoxylin and eosin (Padtan Teb Inc., 
Tehran, Iran).  
In this study, Kim’s method was used to 
harvest DBM (13). After separating long 
femoral and tibia bones of 20 rats, the end of 
these bones were placed in cold sterile distilled 
water, the bone marrow was extruded and the 
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Figure 3. Tissue section from the alveolar socket 
of the third group [first week]. 1) DBM, 2) 
Cellular infiltration, 3) Forming bone trabeculas 
 
 
Figure 5. Tissue section from the alveolar socket 
of the second group [First week]. 1) Bone, 2) 
Connective tissue, 3) Hematoma 
 
separated. The following steps were performed 
sequentially: 
1) Immersion of the specimens in absolute pure 
ethanol for 1 hour;  
2) Immersion in ethyl ether for half an hour;  
3) Placing it in an oven (temperature of 36Pº PC) 
for 1 night; 
4) Milling and powdering the bone; 
5) Immersing in 0.5% normal chloridric acid 
solutions for 3 h and then irrigating with water; 
6) Immersing in ethanol solution for 1 hour and 
in ether for half an hour;  
7) Putting in oven in the temperature of 36Pº PC 
for 1 night;  
8) Keeping the prepared material in the 
temperature of 2-4Pº PC. 
All mentioned procedures were performed in 
the sterile condition.  
 
Results  
At the end of the first week, osteoblastic 
activity   and    osseous   trabeculas   formation 
 
Figure 4. Tissue section from trabecular bone of 
the third group [second week]. 1) Bone 
trabeculas, 2) Vessels, 3) Osteocytes 
 
 
Figure 6. Tissue section from the formed bone in 
the alveolar socket of the second group [second 
week]. 1) Connective tissue, 2) Osteoblasts, 3) 
Osteocytes, 4) Vessels 
 
occurred around DBM and collagen fibers in 
group 4 (insulin treated). DBM particles were 
detectable with sharp borders and acellular 
surface or empty lacuna. These changes were 
clearly evident in four animals (80%). At the 
end of the second week, intramembranous 
bone, vessel and connective tissue formation 
occurred (Figures 1, 2). 
In the third group (diabetic and DBM), 
inflammation and cellular infiltration occurred 
at the end of the first week. Limited bone 
formation around DBM particles was detected; 
activated and DBM fragmenting macrophages 
and osteoclasts were also observed (two rats, 
40%). However, no changes occurred in some 
areas. In this group, new-formed trabecula, 
connective tissue and lots of dilated blood 
vessels were seen at the end of the second week 
(Figures 3-4). In group 2 (diabetic), hematoma 
was the dominant tissue profile at the end of the 
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Figure 7. Tissue section from the alveolar socket 
of the control group [First week]. 1) Connective 
tissue, 2) Cells during conversion to osteoblast, 3) 
Vessels, 4) Fine forming trabeculas 
 
limited bone formation, connective tissue, 
dilated vessels and intramembranous bone 
formation occurred (Figures 5, 6).  
In group 1, bone formation was limited to 
periodontal ligament tissue area around the 
extracted tooth at the end of the first week; 
inflammation and dilated vessels were also 
observed. At the end of second week, bony 
islands formed by means of intramembranous 
bone formation, dilated vessels, new 
osteoblasts; connective tissue could also be 
seen (Figures 7, 8) 
 
Discussion 
In diabetic rats treated with insulin (group 4), 
DBM had favorable effects on GBR. This 
caused the DBM particles to be surrounded by 
osteoblast cells and osteoid. Group 3 showed 
more bone formation than group 2; therefore 
we can conclude that DBM may induce 
effective GBR. According to these results 
DBM had a little inductive effect on the 
untreated diabetic group (group 4); this may be 
due to other factors such as pH changes and 
protein catabolism which will decrease its 
effects. 
It also seems that the control of blood sugar 
with insulin is an effective measure to decrease 
the severity of inflammation and protein 
catabolism in group 4 and increase the bone 
tissue formation.  Final glycolysis products will 
have a negative effect on bone repair and it 
decreases bone formation. Chay et al. showed 
that mesenchymal cells, preosteoblasts and 
osteocytes could be seen around DBM particles 
on  the  15PthP day when  implanting  DMB in the  
 
Figure 8. Tissue section from the alveolar sockets 
osseous trabecula of the control group [second 
week]. 1) Osteoblast, 2) Formated bone, 3) 
Vessels, 4) Connective tissue 
 
cranium (14). In the control group, some 
changes were observed in PDL cells though no 
osteoblast and osteoid material was detected. It 
seems that DBM particles may induce bone 
formation by attracting multipotential cells and 
stimulating their differentiation to osteoblasts. 
Some reports claim that bone formation around 
these particles is due to cytokine release from 
DBM and invasion of multipotential cells to the 
injured area (15). It is likely that DBM releases 
cytokines or DMPs and that the cavities present 
in the DBM particles take part in 
biomineralization. Note that this mechanism 
requires important factors such as collagen, 
appropriate pH and hydroxyl groups that 
become defective in diabetes (2,16). Even 
though DBM has good ability to form bone and 
is an appropriate graft material; more 
investigations are still required (10). 
At the end of the first week, fine trabeculae 
were seen around DBM particles in group 3; 
cellular infiltration and inflammation were also 
dominant. At the end of the second week, 
minor osteogenesis became visible in some 
areas. Due to the inflammatory activity, 
destruction and fragmentation of DBM 
particles, limited ontogenesis also occurred.  In 
this group at the end of the second week, 
cellular infiltration was still present around 
bone, although osteogenesis activity was 
detected in non-treated areas. DBM effects on 
guided osteogenesis were seen in 40% of our 
samples; even though in some reports, 
unpredictable biologic behavior of DBM is 
mentioned (16). However, DBM osteogenesis 
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Callan (3), but DBM effectiveness has been 
decreased to some extent because of metabolic 
changes and when inflammation superimposes. 
Samples in this group had obviously delayed 
osteogenesis.   
In group 1, at the end of the first week, 
osteogenesis was observed with peripheral to 
central direction in some parts of remained 
PDL. Current up to date research has 
demonstrated that rapid osteogenesis after tooth 
extraction in normal tissue is the result of PDL 




This study showed that DBM can have 
inductive effects in rats with controlled 
diabetes; DBM seems to stimulate 
osteoprogenitor cells to differentiate into 
osteoblasts. A good recommendation would be 
to carry our further studies with DBM in 
diseased conditions and control the qualitive 
and quantitive factors. 
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